These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36707524)

  • 1. Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study.
    Cohen A; Naslund JA; Chang S; Nagendra S; Bhan A; Rozatkar A; Thirthalli J; Bondre A; Tugnawat D; Reddy PV; Dutt S; Choudhary S; Chand PK; Patel V; Keshavan M; Joshi D; Mehta UM; Torous J
    Schizophrenia (Heidelb); 2023 Jan; 9(1):6. PubMed ID: 36707524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital phenotyping data and anomaly detection methods to assess changes in mood and anxiety symptoms across a transdiagnostic clinical sample.
    Cohen A; Naslund J; Lane E; Bhan A; Rozatkar A; Mehta UM; Vaidyam A; Byun AJS; Barnett I; Torous J
    Acta Psychiatr Scand; 2024 May; ():. PubMed ID: 38807465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse prediction in schizophrenia through digital phenotyping: a pilot study.
    Barnett I; Torous J; Staples P; Sandoval L; Keshavan M; Onnela JP
    Neuropsychopharmacology; 2018 Jul; 43(8):1660-1666. PubMed ID: 29511333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
    Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J
    Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study.
    Lakhtakia T; Bondre A; Chand PK; Chaturvedi N; Choudhary S; Currey D; Dutt S; Khan A; Kumar M; Gupta S; Nagendra S; Reddy PV; Rozatkar A; Scheuer L; Sen Y; Shrivastava R; Singh R; Thirthalli J; Tugnawat DK; Bhan A; Naslund JA; Patel V; Keshavan M; Mehta UM; Torous J
    Digit Health; 2022; 8():20552076221133758. PubMed ID: 36386246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study.
    Ranjan T; Melcher J; Keshavan M; Smith M; Torous J
    Schizophr Res; 2022 May; 243():64-69. PubMed ID: 35245703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital phenotyping correlates of mobile cognitive measures in schizophrenia: A multisite global mental health feasibility trial.
    Cohen A; Joshi D; Bondre A; Chand PK; Chaturvedi N; Choudhary S; Dutt S; Khan A; Langholm C; Kumar M; Gupta S; Nagendra S; Reddy PV; Rozatkar A; Sen Y; Shrivastava R; Singh R; Thirthalli J; Tugnawat DK; Bhan A; Naslund JA; Vaidyam A; Patel V; Keshavan M; Mehta UM; Torous J
    PLOS Digit Health; 2024 Jun; 3(6):e0000526. PubMed ID: 38941349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smartphone Health Assessment for Relapse Prevention (SHARP): a digital solution toward global mental health.
    Rodriguez-Villa E; Mehta UM; Naslund J; Tugnawat D; Gupta S; Thirtalli J; Bhan A; Patel V; Chand PK; Rozatkar A; Keshavan M; Torous J
    BJPsych Open; 2021 Jan; 7(1):e29. PubMed ID: 33407986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomaly detection to predict relapse risk in schizophrenia.
    Henson P; D'Mello R; Vaidyam A; Keshavan M; Torous J
    Transl Psychiatry; 2021 Jan; 11(1):28. PubMed ID: 33431818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classifying and clustering mood disorder patients using smartphone data from a feasibility study.
    Langholm C; Breitinger S; Gray L; Goes F; Walker A; Xiong A; Stopel C; Zandi P; Frye MA; Torous J
    NPJ Digit Med; 2023 Dec; 6(1):238. PubMed ID: 38129571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks.
    Adler DA; Ben-Zeev D; Tseng VW; Kane JM; Brian R; Campbell AT; Hauser M; Scherer EA; Choudhury T
    JMIR Mhealth Uhealth; 2020 Aug; 8(8):e19962. PubMed ID: 32865506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Associations Between Screen Time and Symptomatology in Individuals With Serious Mental Illness: Longitudinal Observational Study.
    Henson P; Rodriguez-Villa E; Torous J
    J Med Internet Res; 2021 Mar; 23(3):e23144. PubMed ID: 33688835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital phenotyping adherence, feasibility, and tolerability in outpatients with schizophrenia.
    Raugh IM; James SH; Gonzalez CM; Chapman HC; Cohen AS; Kirkpatrick B; Strauss GP
    J Psychiatr Res; 2021 Jun; 138():436-443. PubMed ID: 33964681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial.
    Lewis S; Ainsworth J; Sanders C; Stockton-Powdrell C; Machin M; Whelan P; Hopkins R; He Z; Applegate E; Drake R; Bamford C; Roberts C; Wykes T
    J Med Internet Res; 2020 Aug; 22(8):e17019. PubMed ID: 32788150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and correlations of smartphone meta-data toward dynamic understanding of depression and suicide risk in schizophrenia.
    Henson P; Torous J
    Int J Methods Psychiatr Res; 2020 Jun; 29(2):e1825. PubMed ID: 32333471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Neuropsychiatric Sequalae of Perceived COVID-19 Exposure in College Students: A Pilot Digital Phenotyping Study.
    Patel SK; Torous J
    Front Psychiatry; 2021; 12():788926. PubMed ID: 35082701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.
    Eisner E; Bucci S; Berry N; Emsley R; Barrowclough C; Drake RJ
    Schizophr Res; 2019 Jun; 208():105-113. PubMed ID: 30979665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital biomarkers from geolocation data in bipolar disorder and schizophrenia: a systematic review.
    Fraccaro P; Beukenhorst A; Sperrin M; Harper S; Palmier-Claus J; Lewis S; Van der Veer SN; Peek N
    J Am Med Inform Assoc; 2019 Nov; 26(11):1412-1420. PubMed ID: 31260049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.
    Buck B; Scherer E; Brian R; Wang R; Wang W; Campbell A; Choudhury T; Hauser M; Kane JM; Ben-Zeev D
    Schizophr Res; 2019 Jun; 208():167-172. PubMed ID: 30940400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse.
    Eisner E; Drake RJ; Berry N; Barrowclough C; Emsley R; Machin M; Bucci S
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11568. PubMed ID: 30924789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.